MX2011002080A - Extractos inmunomoduladores de bacteria de lactobacillus y metodos de manufactura y uso de los mismos. - Google Patents

Extractos inmunomoduladores de bacteria de lactobacillus y metodos de manufactura y uso de los mismos.

Info

Publication number
MX2011002080A
MX2011002080A MX2011002080A MX2011002080A MX2011002080A MX 2011002080 A MX2011002080 A MX 2011002080A MX 2011002080 A MX2011002080 A MX 2011002080A MX 2011002080 A MX2011002080 A MX 2011002080A MX 2011002080 A MX2011002080 A MX 2011002080A
Authority
MX
Mexico
Prior art keywords
extract
lactobacillus
hours
extracts
bacterial
Prior art date
Application number
MX2011002080A
Other languages
English (en)
Spanish (es)
Inventor
Carlo Chiavaroli
Jacques Alain Bauer
Marco Salvagni
Jean-Pierre Leon Vigroux
Laetitia Leela Gisele Chalvet
Original Assignee
Om Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Pharma filed Critical Om Pharma
Publication of MX2011002080A publication Critical patent/MX2011002080A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2011002080A 2008-09-04 2008-09-04 Extractos inmunomoduladores de bacteria de lactobacillus y metodos de manufactura y uso de los mismos. MX2011002080A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/010350 WO2010027344A1 (en) 2008-09-04 2008-09-04 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof

Publications (1)

Publication Number Publication Date
MX2011002080A true MX2011002080A (es) 2011-03-29

Family

ID=41797341

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011002080A MX2011002080A (es) 2008-09-04 2008-09-04 Extractos inmunomoduladores de bacteria de lactobacillus y metodos de manufactura y uso de los mismos.

Country Status (11)

Country Link
JP (1) JP2012502026A (ru)
KR (1) KR20110051268A (ru)
CN (1) CN102143756A (ru)
AU (1) AU2008361375B2 (ru)
BR (1) BRPI0822997A2 (ru)
CA (1) CA2733249A1 (ru)
IL (1) IL211041A0 (ru)
MX (1) MX2011002080A (ru)
RU (1) RU2500412C2 (ru)
WO (1) WO2010027344A1 (ru)
ZA (1) ZA201100899B (ru)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2670415A4 (en) 2011-02-02 2014-11-26 Justbio Inc FUNCTIONAL FOODS AND BEVERAGES WITH SYNERGISTIC PROPERTIES FOR THE PROMOTION OF HOMEOSTASIS
SG193589A1 (en) * 2011-03-29 2013-10-30 Nestec Sa Natural derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with a further improved immune profile
US9309492B2 (en) * 2011-03-29 2016-04-12 Nestec S.A. Derivative of the Lactobacilus johnsonii strain CNCM I-1225, deficient in D-lactic acid production and with an improved shelf life
US20130022586A1 (en) 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
SG10202013014RA (en) 2012-01-16 2021-02-25 Mckenna Elizabeth Compositions and Methods for the Treatment of Hepatic Diseases and Disorders
EP2898073A4 (en) 2012-09-21 2016-03-23 Elizabeth Mckenna Naturally-occurring CPG-oligonucleotide compositions and therapeutic applications thereof
US20150017208A1 (en) * 2013-07-12 2015-01-15 National Yang-Ming University Lactic acid bacterium having immunomodulatory and anti-allergic effects
JP6821643B2 (ja) * 2013-09-26 2021-01-27 雪印メグミルク株式会社 免疫疾患予防剤
JP6491422B2 (ja) * 2013-09-26 2019-03-27 雪印メグミルク株式会社 免疫疾患予防剤
CN104957260B (zh) * 2014-03-07 2018-07-24 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
KR101627806B1 (ko) * 2014-06-23 2016-06-07 한국식품연구원 락토바실러스 속 균주의 면역증강 활성을 증가시키는 배양 방법
JP6940305B2 (ja) * 2017-06-01 2021-09-22 株式会社明治 チーズ風味素材の製造方法
KR102335710B1 (ko) 2017-10-31 2021-12-07 (주)아모레퍼시픽 유산균 유래의 세포밖 베지클을 포함하는 면역조절용 조성물
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途
CN112534043B (zh) 2018-05-09 2024-04-26 Ko生物技术有限公司 副干酪乳杆菌菌株及其用途
CN112469404A (zh) * 2018-06-07 2021-03-09 国立大学法人金泽大学 肾损伤的预防或治疗用的药物组合物
TW202011834A (zh) * 2018-06-07 2020-04-01 國立大學法人金澤大學 腎損傷之預防或治療用之醫藥組合物
CN109007842A (zh) * 2018-10-29 2018-12-18 广州普维君健药业有限公司 具有防治过敏功效的益生菌组合物及其应用
KR102156829B1 (ko) * 2019-02-22 2020-09-18 가톨릭대학교 산학협력단 마이크로바이옴 혼합물을 포함하는 면역 질환의 예방 및 치료용 조성물
CN109628359B (zh) * 2019-02-22 2021-03-02 江南大学 一株可缓解过敏性哮喘的罗伊氏乳杆菌及其应用
CR20210515A (es) 2019-03-14 2022-03-28 Om Pharma Sa Extractos bacterianos estables como fármacos
CN110643541B (zh) * 2019-10-25 2021-08-24 江南大学 一株可调节过敏性哮喘Th2/Th1平衡的干酪乳杆菌及其应用
CN111053789A (zh) * 2019-11-26 2020-04-24 湖南营养树生物科技有限公司 调节免疫系统的方法和组合物
EP4084784A4 (en) * 2020-01-13 2024-01-17 Monash University COMPOSITIONS AND METHODS
CN111548961A (zh) * 2020-05-15 2020-08-18 郑州和合生物工程技术有限公司 改善过敏性疾病的益生菌组合物、益生菌组合物菌粉及制备方法，应用
CA3180737A1 (en) * 2020-06-06 2021-12-09 Nicholas T. Monsul Materials and methods for inhibiting a viral infection, including a coronavirus infection
CN111991428A (zh) * 2020-06-12 2020-11-27 郑州和合生物工程技术有限公司 一种具有改善哮喘作用的益生菌组合物及其制备方法
CN112057479B (zh) * 2020-11-16 2021-02-12 河北一然生物科技有限公司 一种能够缓解抗生素引起腹泻的益生菌组合物
KR102424594B1 (ko) * 2020-11-30 2022-07-25 파이토지노믹스 주식회사 항염 활성 및 유해 미생물에 대한 항균 활성을 가지는 락토바실러스 퍼멘텀 okbl-l.fe 1 균주 및 이의 용도
KR20230001127A (ko) 2021-06-28 2023-01-04 농업회사법인 산청바이오진생마을 주식회사 새싹 인삼 라떼 제조방법
KR20230131450A (ko) * 2022-03-03 2023-09-13 한국생명공학연구원 N-카바밀-l-글루탐산을 포함하는 염증성 질환의 치료용 조성물
CN114774302B (zh) * 2022-03-09 2023-06-16 善恩康生物科技（苏州）有限公司 植物乳杆菌cqpc02在制备用于预防和/或治疗狼疮性肾炎的产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH532903A (fr) * 1971-06-25 1973-01-31 Nestle Sa Procédé d'extraction de protéines à partir de cellules de microorganismes
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
PE20030274A1 (es) * 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
RU2302458C2 (ru) * 2001-07-26 2007-07-10 Элиментери Хелс Лимитед Пробиотический штамм lactobacillus salivarius (варианты), пробиотический препарат на их основе и способ лечения или предупреждения с использованием штаммов lactobacillus salivarius
US7025998B2 (en) * 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health
CA2557834C (en) * 2004-03-04 2012-05-22 E-L Management Corporation Skin treatment method with lactobacillus extract
AR052472A1 (es) * 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
JP2007269737A (ja) * 2006-03-31 2007-10-18 Morinaga Milk Ind Co Ltd インターロイキン産生調節剤、該インターロイキン産生調節剤を含む医薬組成物及び飲食品、並びにその製造方法
JP5019961B2 (ja) * 2006-06-26 2012-09-05 株式会社ヤクルト本社 インターロイキン１０産生促進剤

Also Published As

Publication number Publication date
RU2011112781A (ru) 2012-10-10
CA2733249A1 (en) 2010-03-11
AU2008361375B2 (en) 2014-05-22
BRPI0822997A2 (pt) 2015-06-23
KR20110051268A (ko) 2011-05-17
ZA201100899B (en) 2012-05-30
JP2012502026A (ja) 2012-01-26
IL211041A0 (en) 2011-04-28
CN102143756A (zh) 2011-08-03
RU2500412C2 (ru) 2013-12-10
WO2010027344A1 (en) 2010-03-11
AU2008361375A1 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
AU2008361375B2 (en) Immunomodulatory extracts from Lactobacillus bacteria and methods of manufacturing and use thereof
Renz et al. The immunological basis of the hygiene hypothesis
Galdeano et al. Mechanisms involved in the immunostimulation by probiotic fermented milk
US9463209B2 (en) Bacterial extract for respiratory disorders and process for its preparation
US9198961B2 (en) Bacterial extract for digestive or urinary tract disorders and process for its preparation
ES2345188T3 (es) Preparaciones de bacterias gram positivas para el tratamiento de enfermedades que comprenden una mala regulacion inmune.
US20100055082A1 (en) Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
EP2161329A1 (en) Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
TW201010711A (en) Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
AU2013200193B2 (en) Bacterial extract for digestive or urinary tract disorders and process for its preparation
Підгорський et al. EFFECTS OF DRY ENZYMATIC LYSATE DEL-IMMUNE V® ON CYTOKINE PRODUCTION IN THE EXPERIMENTAL MODELS
ITMI20070597A1 (it) Metodo di frazionamento di organismi unicellulari e prodotti ottenuti da tale processo

Legal Events

Date Code Title Description
FA Abandonment or withdrawal